Results 151 to 160 of about 35,271 (262)

Development of Nipah virus mRNA vaccine for pandemic preparedness. [PDF]

Front Immunol
Kim JI, Fatima M, Seo EH, Park PG, Hong KJ.   +4 more
europepmc   +1 more source

Recognizing and managing deventilation syndrome in patients with COPD. [PDF]

J Bras Pneumol
Carvalho I, Jacob M, Marinho A.
europepmc   +1 more source

Laryngeal Responses During Non-Invasive Ventilation in Stable Chronic Obstructive Pulmonary Disease: An Observational Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Brekka AK, Solli PV, Indrekvam S, Engeset MS, Røksund OD, Lehmann S, Clemm HH, Halvorsen T, Heimdal JH, Murphy PB, Vollsæter M, Andersen TM.   +11 more
europepmc   +1 more source

Nipah virus matrix protein promotes NF-κB activation by targeting multiple signaling modulators. [PDF]

J Virol
Ye C, Ma X, Ke X, Yao Z, Liu R, Li T, Zhang P, Wakjira BS, Tang S, Liu F, Ye Z, Xie Y, Chen Q.   +12 more
europepmc   +1 more source

The Nipah virus threat in India: Epidemiological trends, risk drivers, and lessons for pandemic preparedness. [PDF]

PLoS Pathog
Apoorva, Singh SK.
europepmc   +1 more source

The NAVIGATE trial: early identification and management of mild acute hypoxemic failure, does timing matter outside ICUs? [PDF]

J Thorac Dis
Frat JP, Coudroy R, Thille AW.
europepmc   +1 more source

Exploratory Analysis of Bedside Variables Associated with Transition Failure in a Selected Cohort of Pediatric Patients Stepped Down from Non-Invasive Ventilation to High-Flow Nasal Cannula After Planned Extubation. [PDF]

J Clin Med
Bingöl İ, Uçmak H, Altınsoy KE.
europepmc   +1 more source

High-flow nasal cannula versus noninvasive ventilation in stabilized hypercapnic exacerbation: a physiological crossover trial. [PDF]

Ann Intensive Care
Vieira F, Schreiber A, Docci M, Rodrigues A, Phoophiboon V, Subira C, Ko M, Sousa MLA, Pham T, Piraino T, Coudroy R, Cavalot G, Telias I, Junhasavasdikul D, Dres M, Sklar MC, Brochard L.   +16 more
europepmc   +1 more source

The Silent Spillover Threat: Nipah Virus Epidemiology, Pathogenesis, Clinical Manifestations, and Advances in Therapeutics and Vaccine Development. [PDF]

Microorganisms
Magklara EP, Kkirgia M, Tsantes AG, Ioannou P, Mpakosi A, Mougiou V, Iliodromiti Z, Boutsikou T, Iacovidou N, Sokou R.   +9 more
europepmc   +1 more source

Feasibility of NIV-NAVA as a primary respiratory support and its clinical impacts in a targeted group of preterm infants: protocol for a prospective observational study. [PDF]

BMJ Open
Cho H, Jung YH, Park J, Yang HJ, Kim MJ, Lee J.   +5 more
europepmc   +1 more source